01/17/14 - 03:30 PM EST
Biotechnology stocks have been front and center this week amidst the J.P. Morgan Healthcare conference, the big conference held in San Francisco each January where so many companies reveal important outlooks for the year and important pipeline updates. Historically, biotechnology stocks have outperformed during this conference week -- and we have seen broad-based strength from the group -- but more importantly, investors are provided with a reiteration of some of the strong themes that will dominate 2014...READ FULL POST
01/16/14 - 07:27 PM EST
2013 was the year of the Permian Basin, 2012 was the year of the Eagle Ford, and 2011 was the year of the Bakken. What is the theme for 2014? At this point, most of the plays have been discovered, with even new finds in the Utica "known." So key is choosing the names with the BEST acreage -- because they will continue to outperform....READ FULL POST
01/16/14 - 03:55 PM EST
Another side of the security play: Keep an eye out for LifeLock's interview on Mad Money TonightREAD FULL POST
01/16/14 - 02:17 PM EST
Yes, Yahoo CEO Marissa Mayer's decision to fire COO Henrique de Castro after only a 15-month tenure reveals that Yahoo's core business continues to struggle. But is this news? No! Mayer has the benefit of taking risks in the core business (think: expensive Tumblr acquisition for example), and being brutal at times when it comes to management decisions, because of the Alibaba halo....READ FULL POST
01/16/14 - 02:14 PM EST
The bloodbath in retail in the last couple of weeks doesn't seem to want to come to an end, with a dismal report from Best Buy, one of the best performers in 2013, today. This week marked one of the most pessimistic ICR XChange conferences in recent years. So is anything buyable? Here are three names that I think are...READ FULL POST
01/16/14 - 08:55 AM EST
While we don't have pricing details yet for many of 2014's hyped potential IPOs, it's key to know which names to have on your radar. This year holds a good deal of promise for the IPO market, where investors want to seek new names to play strong themes and with an appetite for growth...READ FULL POST
01/15/14 - 01:06 PM EST
U.S. markets are up today, as Bank of America's profit surged. Tesla is rising further after a strong Model S report yesterday. 3D names, like 3D Systems and Stratasys , are falling after peer ExOne reported disappointing numbers. Burberry is trading up after strong retail sales growth and Apple is in focus as CEO Tim Cook held a press conference in China for the company's new agreement with China Mobile. General Motors GM announces its $1.20 per share annual dividend....READ FULL POST
01/14/14 - 07:02 PM EST
When not talking about potential privacy issues, Many analysts and commentators have been balking at the price Google paid for Nest. A whopping $3.2 billion in cash ain't cheap, after all.But one thing not enough people are saying? Why not! Google ended last quarter with about $56.5 billion in cash. Even though the company is investing in research & development and its own growth, its $12 billion annual free cash flow generation still leaves a lot on the table.READ FULL POST
01/13/14 - 06:07 PM EST
Breaking up ain't hard to do. The celebration of Beam's chart is more than a one day spike - it is years of value creationREAD FULL POST
01/13/14 - 01:01 PM EST
Today kicked off with a 'merger Monday' takeover of Beam by Japan's Suntory and was rounded out by disappointing retail data from the likes of Lululemon, Express, Ascena and SodaStream. In food, we got another smart tuck-in acquisition from health play Hain Celestial and good numbers out of Wendys...READ FULL POST
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.